Edition:
United States

Healthcare Facilities & Services

Page 2

H.I.G. Capital announces sale of equity stake in Surgery Partners

Monday, 15 May 2017 03:24pm EDT

May 15 (Reuters) - H.I.G. Capital :Entered into an agreement to sell its existing stake in Surgery Partners Inc to Bain Capital private equity.Funding for transaction will be provided in part by Bain Capital Private Equity.Surgery partners will acquire NSH from Irving Place Capital for approximately $760 million.Surgery Partners and National Surgical Healthcare entered into a definitive merger agreement.

Life Healthcare HY HEPS declines 71.3 pct

Friday, 12 May 2017 01:05am EDT

May 12 (Reuters) - Life Healthcare Group Holdings Ltd :HY revenue up 22.6% to r9.6 billion.HY normalised EBITDA up 15.2% to r2.4 billion.Declares interim dividend of 35 cents per share.HY headline earnings per share decreased 71.3 percent to 26.7 cents.Net debt to normalised EBITDA as at 31 March 2017 was 3.99 times versus 1.67 times at 30 September 2016.Increase in net debt is primarily due to r14.6 billion raised in respect of acquisition of alliance medical.Approved r1.2 billion of its 2017 capital expenditure programme to date."General market conditions in Southern Africa are not expected to improve substantially in foreseeable future".Expect continued pressure on acute hospital volumes.Well-positioned to continue driving its complementary services business through expansion in Southern Africa and Alliance Medical.Completion of rights issue will result in group's net debt to EBITDA decreasing to approximately 2.35 times.In southern africa, group aims to add over 112 acute hospital brownfield beds in next six months.Pressure on costs and occupancies will continue; implemented measures to mitigate impact of these pressures.FY results expected to show yoy decline of more than 20% in EPS (minimum decline of 31.0 cps) and HEPS (minimum decline of 38.5 cps).Expects FY results decline due to impact of transaction costs, increased funding costs related to alliance medical acquisition, impairment of Poland.

Premier reports Q3 revenue $379.8 million

Monday, 8 May 2017 04:03pm EDT

May 8 (Reuters) - Premier Inc :Premier Inc. Reports fiscal 2017 third-quarter results.Q3 revenue $379.8 million versus I/B/E/S view $401.9 million.Q3 non-GAAP earnings per share $0.52.Q3 loss per share $1.58.Q3 earnings per share view $0.50 -- Thomson Reuters I/B/E/S.Says updated fiscal 2017 guidance.Premier Inc says qtrly supply chain services segment revenue rose 34% and performance services segment revenue increased 10%.Sees 2017 total net revenue $1,432.0 million - $1,472.0 million.Says narrowing and adjusting guidance to reflect reduced revenue contributions from company's integrated pharmacy business.Premier Inc says narrowing and adjusting 2017 guidance to also reflect more moderate full-year growth expectations for performance services segment.Premier Inc sees 2017 non-GAAP adjusted fully distributed eps $1.89 - $1.94 versus previous guidance eps of $1.80 - $1.93.FY2017 earnings per share view $1.88, revenue view $1.49 billion -- Thomson Reuters I/B/E/S.

Laboratory Corp Of America Q1 adjusted EPS $2.22

Tuesday, 25 Apr 2017 06:56am EDT

April 25 (Reuters) - Laboratory Corporation Of America Holdings ::Laboratory Corporation Of America Holdings announces 2017 first quarter results and updates 2017 guidance.Q1 adjusted earnings per share $2.22.Q1 earnings per share $1.84.Q1 earnings per share view $2.20 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $9.20 to $9.60.Q1 revenue $2.41 billion versus I/B/E/S view $2.41 billion.Sees 2017 net revenue growth of 3.5% to 5.5% over 2016.Labcorp- updated outlook for 2017, net revenue growth of 3.5% to 5.5% over 2016.Fy2017 earnings per share view $9.60, revenue view $9.94 billion -- Thomson Reuters I/B/E/S.Labcorp sees 2017 free cash flow of $925 million to $975 million.Labcorp says backlog at end of quarter was $5.2 billion.Labcorp - company expects approximately $2.1 billion of current backlog to convert into revenue in next twelve months.Labcorp says remains on track to deliver cost synergies of $100 million related to acquisition of Covance through three-year period ending in 2017.Labcorp says company has expanded its launchpad initiative to include covance drug development.Labcorp says initiative will consist of two phases implemented over three years.Labcorp says first phase of initiative is intended to better align covance drug development's resources with its near-term outloo.Labcorp says first phase is expected to generate pre-tax savings of approximately $20 million in 2017.

Winning Health Technology Group sees Q1 FY 2017 net profit up 15 pct to 30 pct

Monday, 10 Apr 2017 11:35am EDT

Winning Health Technology Group Co Ltd <300253.SZ> : Sees Q1 FY 2017 net profit to increase by 15 percent to 30 percent, or to be 25.5 million yuan to 28.8 million yuan . Says Q1 FY 2016 net profit was 22.2 million yuan .The reasons for the forecast are improved main business and developed innovative business.

Aevis Victoria FY total revenues up at CHF 592.6 mln

Monday, 27 Mar 2017 01:01am EDT

Aevis Victoria SA : FY total revenues grew by 2.9% to 592.6 million Swiss francs ($599.98 million)(2015: 576.1 million francs) and net revenues (medical fees excluded) amounted to 517.1 million francs (2015: 508.6 million francs) . The board of directors will propose to the annual general meeting a distribution from capital contribution reserves of 0.55 francs per share, in line with its long-term distribution policy. . FY profit for the period amounts to 2.7 million Swiss francs . For the entire business year 2017, Aevis Victoria SA expects to realise a total revenue of more than 700 million Swiss francs based on an unchanged portfolio consolidated over a 12-month period . Sees FY EBITDA of more than 100 million Swiss francs .FY EBITDA reached chf 74.6 million or 14.4% of turnover and the ebit increased by 31.8% from 23.9 million Swiss francs to 31.4 million francs.

Yamane Medical to merge unit Yaesu Cook Life Corp

Thursday, 16 Mar 2017 01:55am EDT

Yamane Medical Corp <2144.T> : Says it plans to merge its wholly owned unit Yaesu Cook Life Corp, which is mainly engaged in food service business and life support business, effective on Oct. 1 .Says the unit will be dissolved after transaction.

Aevis Victoria: statement on the report of board of directors of Lifewatch

Monday, 13 Mar 2017 02:05am EDT

Aevis Victoria SA : Position statement on the report of the board of directors of Lifewatch Ltd. . Regrets that committee created for this occasion recommended to reject its friendly offer . Evaluation of Ernst & Young values exchange offer for Lifewatch shareholders between 12.40 Swiss francs and 13.60 francs ($12.31 - $13.50) per Lifewatch share . Is convinced that Lifewatch would benefit from support of a reference shareholder with a strong presence in healthcare sector .Upon successful completion of offer, Lifewatch would become an independently managed subsidiary of Aevis.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary